Paul B. Manning - Jun 17, 2021 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director, 10%+ Owner
Signature
/s/ Kamran Alam, Attorney-in-Fact
Stock symbol
TSHA
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 04:59 PM
Previous filing
May 17, 2021
Next filing
Jun 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSHA Stock Option (right to buy) Award $0 +15.5K $0.00 15.5K Jun 17, 2021 Common Stock 15.5K $25.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest on the earlier of June 17, 2022 or the next annual stockholders meeting, subject to continued service as a director though the applicable vesting date.